Burlington Medical is proud to announce a significant step to enhance its mission to continuously increase its service and value to its customers.
Burlington has established its first European production facility through this week’s acquisition of ProtecX Medical Ltd, in Hitchin, UK. Joining forces with this first class facility allows us to cut costs to our European customers, but more importantly, increases our ability to dramatically reduce lead times to those customers, and greatly increase the level of our service both before and after the sale.
These are exciting times as the company will continue to use both brand names in its UK and export markets, and plans to introduce the ProtecX brand into the US, a new market for ProtecX.
John Williams, Burlington’s Chief Executive officer, commented “After a multiyear expansion of our customer base in the US, the company has turned its attention to better serving its customer base in Europe and beyond. When we discovered ProtecX Medical, we realized we had found an ideal fit to achieve our goals. ProtecX produces high quality products, with well-trained employees and a company culture that is very compatible with the Burlington values of high customer service and supportive of its team of employees. We expect to achieve great things with this enhanced team.”